l-carnitine chemotherapy (500mg) Carnitine | HealthyPlace
Description
Cabrera for standard clinical testing
In the MOLT-4 human leukemia cell line, quercetin interacts with the PI3K-dependent/AKT pathway, leading to a decrease in mammalian target of rapamycin (mTOR) activity
10.1016/j.tins.2019.08.001 Trends Neurosci
Common side effects are in bold, but there may be others
